Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory L. Verdine currently holds 64,000 shares of ENANTA PHARMACEUTICALS INC (ENTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory L. Verdine has been a net seller of ENTA stock. They have purchased $46.5K and sold $2.7M worth of shares.
Gregory L. Verdine's most recent insider trade was on Oct 5, 2026, when they sold 64,000 shares at $0.00 per share.
Gregory L. Verdine serves as Executive at ENANTA PHARMACEUTICALS INC (ENTA). They have executed 16 insider transactions totaling $2.8M over their tenure at the company.
Gregory L. Verdine holds the position of Executive at ENANTA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Gregory L. Verdine has shown a selling trading pattern, with $46.5K in total purchases and $2.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory L. Verdine was on Jun 15, 2016, when they sold $868.4K worth of WVE shares. This transaction involved 52,000 shares at $16.70 per share.
Gregory L. Verdine currently owns 64,000 shares of ENANTA PHARMACEUTICALS INC (ENTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory L. Verdine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory L. Verdine has 16 Form 4 filings on record as an insider at ENANTA PHARMACEUTICALS INC.
Set alerts for Gregory L. Verdine and 40,000+ other insiders.